| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K E Towbin, E M Dykens, R G Puglies. Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome. Journal of the American Academy of Child and Adolescent Psychiatry. vol 33. issue 5. 1994-09-12. PMID:7520035. |
clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome. |
1994-09-12 |
2023-08-12 |
Not clear |
| K E Towbin, E M Dykens, R G Puglies. Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome. Journal of the American Academy of Child and Adolescent Psychiatry. vol 33. issue 5. 1994-09-12. PMID:7520035. |
additional features of the case are the early social and developmental delays preceding schizophrenia, the response of symptoms of childhood-onset schizophrenia to clozapine, and the reduction in tardive dyskinesia symptoms while taking clozapine. |
1994-09-12 |
2023-08-12 |
Not clear |
| L K Jacobsen, M C Walker, J E Edwards, P B Chappell, J L Woolsto. Clozapine in the treatment of a young adolescent with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry. vol 33. issue 5. 1994-09-12. PMID:8056727. |
clozapine in the treatment of a young adolescent with schizophrenia. |
1994-09-12 |
2023-08-12 |
Not clear |
| J A Frazier, C T Gordon, K McKenna, M C Lenane, D Jih, J L Rapopor. An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry. vol 33. issue 5. 1994-09-12. PMID:8056728. |
an open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. |
1994-09-12 |
2023-08-12 |
Not clear |
| J A Frazier, C T Gordon, K McKenna, M C Lenane, D Jih, J L Rapopor. An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry. vol 33. issue 5. 1994-09-12. PMID:8056728. |
to review the response of 11 adolescents with childhood-onset schizophrenia to a 6-week open clozapine trial. |
1994-09-12 |
2023-08-12 |
Not clear |
| J M Vanelle, J P Olié, P Lévy-Soussa. New antipsychotics in schizophrenia: the French experience. Acta psychiatrica Scandinavica. Supplementum. vol 380. 1994-09-01. PMID:7914051. |
in france, in most cases, the indication of clozapine is still refractory paranoid schizophrenia. |
1994-09-01 |
2023-08-12 |
Not clear |
| E Klieser, W H Strauss, W Lemme. The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia. Acta psychiatrica Scandinavica. Supplementum. vol 380. 1994-09-01. PMID:8048341. |
the tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia. |
1994-09-01 |
2023-08-12 |
Not clear |
| A Fitton, P Benfiel. Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia. PharmacoEconomics. vol 4. issue 2. 1994-08-25. PMID:10146973. |
clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia. |
1994-08-25 |
2023-08-12 |
Not clear |
| A Fitton, P Benfiel. Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia. PharmacoEconomics. vol 4. issue 2. 1994-08-25. PMID:10146973. |
thus, clozapine is effective against both the positive and negative symptoms of schizophrenia and has a low propensity to cause extrapyramidal effects. |
1994-08-25 |
2023-08-12 |
Not clear |
| A Fitton, P Benfiel. Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia. PharmacoEconomics. vol 4. issue 2. 1994-08-25. PMID:10146973. |
although the acquisition cost of clozapine is high in comparison with that of standard antipsychotics, preliminary cost-effectiveness estimates in patients with treatment-resistant schizophrenia suggest that the clinical benefits of the drug (viz. |
1994-08-25 |
2023-08-12 |
Not clear |
| L R Drew, M M Wood, R T Wa. Initial experiences with clozapine at Kenmore Psychiatric Hospital. The Medical journal of Australia. vol 161. issue 3. 1994-08-16. PMID:8035723. |
to replicate overseas experience with clozapine, a new antipsychotic drug reputed to be effective in producing major improvement in a high proportion of patients with treatment-resistant schizophrenia. |
1994-08-16 |
2023-08-12 |
Not clear |
| R A Dickson, R Williams, J T Dalb. The use of chloral hydrate and sodium amytal during clozapine initiation. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 39. issue 3. 1994-08-15. PMID:8033016. |
the effectiveness of alternate agents sodium amytal and chloral hydrate when initiating clozapine was evaluated in a group of 15 patients suffering from schizophrenia. |
1994-08-15 |
2023-08-12 |
Not clear |
| I Jalenques, A J Couder. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients]. Acta psychiatrica Belgica. vol 92. issue 6. 1994-08-11. PMID:1364281. |
[a new therapeutic approach tp drug-resistant schizophrenia: clozapine. |
1994-08-11 |
2023-08-11 |
Not clear |
| S Kuh. [The role of clozapine in the treatment of schizophrenia]. Duodecim; laaketieteellinen aikakauskirja. vol 106. issue 13. 1994-08-10. PMID:1670340. |
[the role of clozapine in the treatment of schizophrenia]. |
1994-08-10 |
2023-08-11 |
Not clear |
| W H Reid, M Mason, M Topra. Savings in hospital bed-days related to treatment with clozapine. Hospital & community psychiatry. vol 45. issue 3. 1994-06-21. PMID:8188199. |
the authors' aim was to determine whether clozapine was associated with a decrease in state hospital bed-days for patients with chronic schizophrenia. |
1994-06-21 |
2023-08-12 |
Not clear |
| S Szymanski, S Masiar, D Mayerhoff, A Loebel, S Geisler, S Pollack, J Kane, J Lieberma. Clozapine response in treatment-refractory first-episode schizophrenia. Biological psychiatry. vol 35. issue 4. 1994-06-17. PMID:8186332. |
clozapine response in treatment-refractory first-episode schizophrenia. |
1994-06-17 |
2023-08-12 |
Not clear |
| A Breier, R W Buchanan, R W Waltrip, S Listwak, C Holmes, D S Goldstei. The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 10. issue 1. 1994-06-15. PMID:8179790. |
clozapine is an atypical neuroleptic medication with superior efficacy to conventional antipsychotic agents for patients with chronic, symptomatic schizophrenia. |
1994-06-15 |
2023-08-12 |
Not clear |
| Y Levkovitch, N Kaysar, Y Kronnenberg, H Hagai, B Gaon. Clozapine for schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry. vol 33. issue 3. 1994-06-02. PMID:8169194. |
clozapine for schizophrenia. |
1994-06-02 |
2023-08-12 |
Not clear |
| F Macciardi, A Petronis, H H Van Tol, C Marino, M C Cavallini, E Smeraldi, J L Kenned. Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred. Archives of general psychiatry. vol 51. issue 4. 1994-05-18. PMID:7909222. |
among the different dopamine receptors, the d4 dopamine receptor is of particular interest in schizophrenia because of its high affinity for the atypical neuroleptic clozapine. |
1994-05-18 |
2023-08-12 |
human |
| M Sajatovic, L F Ramirez, J T Kenny, H Y Meltze. The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients. Comprehensive psychiatry. vol 35. issue 1. 1994-05-06. PMID:8149726. |
the effect of clozapine, an atypical antipsychotic medication, in five patients with treatment-resistant schizophrenia or schizoaffective disorder and borderline intellectual functioning or mental retardation (mr) was studied. |
1994-05-06 |
2023-08-12 |
Not clear |